Navigation Links
Joslin study finds restricting insulin doses increases mortality risk
Date:2/26/2008

BOSTON Feb. 27, 2008 -- A new study led by researchers at the Joslin Diabetes Center has found that women with type 1 diabetes who reported taking less insulin than prescribed had a three-fold increased risk of death and higher rates of disease complications than those who did not skip needed insulin shots. The new research appears in the March issue of Diabetes Care.

The study highlights the dangers of insulin restriction and concludes that mortality associated with the behavior appears to occur in the context of eating disorder symptoms often exhibited in women with diabetes sometimes referred to as diabulimia in the media.

This 11-year follow-up study of 234 women is one of the first to show an increased risk of mortality as well as higher rates of kidney and foot problems in those who restricted their insulin intake. In addition, the average age of death was younger for those involved in insulin restriction: 45 years of age as compared to 58 years for those who did not restrict.

Thirty percent of the subjects reported restricting their insulin intake at the studys outset. Frequency of the behavior appears to influence mortality risk. Insulin-restricting women who died had reported more frequent insulin restriction and reported more eating disorder symptoms at the studys outset than those insulin-restrictors who were still living at studys end.

Eating disorder symptoms include extreme concern for body weight and shape, judging self worth according to a thin body ideal, restrictive eating patterns, binge eating and other methods of purging calories, such as vomiting.

This is an incredibly important womens health issue in the area of diabetes, said lead author Ann E. Goebel-Fabbri, Ph.D., psychologist and investigator in the Section on Behavioral and Mental Health at Joslin Diabetes Center and instructor at Harvard Medical School. The average age of death was significantly younger in the insulin-restricting gro
'/>"/>

Contact: Kira Jastive
kira.jastive@joslin.harvard.edu
617-732-2418
Joslin Diabetes Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...wswire-USNewswire/ -- The University of Texas M.... a collaborative effort to eradicate breast cancer...er Awareness and Research of the Americas today at...nited States, and Vivian Fernandez de Torrijos, th...nderson in the initiative are the U.S. Department ...
(Date:11/21/2008)...1 U.S. News & World...urance (NCQA) ranked BlueChoice(R) HealthPlan of S...ealth Plans(TM), published in U.S. News & Worl...ed annual ranking ranks the nation,s best health p...n and NCQA accreditation scores. NCQA and U.S. New...
(Date:11/21/2008)...drugs do not cause genetic damage that can lead to...News) -- Two popular medications for treating atte... cause genetic damage linked to an increased risk ...study, done by researchers at Duke University Medi...counters a previous one that reported biomarkers a...
(Date:11/21/2008)...Newswire/ -- For the second year in a row and th...thcare Worldwide,s agency network won more creativ... annual international RX Club Show. , , Ni...a total of 59 RX Club Awards of Excellence, includ...thcare Worldwide agencies include Caudex Medical, ...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4
...ovided an insight into how effective the lead petr...ation about the otter species, examination of the ...ing levels of lead pollution in them. The research...l since lead can damage the central nervous system...
...ty of plastic surgeons, 'Plastic Surgery 2006' is ... The convention that is to be held on October 6-1...o is to be attended by more than 6,000 doctors, me...ors in the field of plastic surgery. It is expect...
...ital and Washington University School of Medicine ...ow children under the age of 16 to// use of all-te...a 10-year review of the injuries. Children have n...torized vehicles, and they're driving them on unev...
...with Florida-based Roskamp Institute to conduct a ...ts possible use in Alzheimer's disease. // The Du...riatrics and Old Age Psychiatry from St James’ Hos...ly Memorial Hospital, Loughlinstown, Mater Hospita...
Other Medicine News:Health News:Annual Conference Of Plastic Surgeons In US To Focus On The Future Of Plastic Surgery 2Health News:Call To Ban Use Of ATVs By Children 2
(Date:11/19/2008)... report basic findings on critical enzyme,s regula...reat an array of disorders , , MEMPHIS, Ten... at St. Jude Children,s Research Hospital have gai...y,s enzyme workhorses called calpains. , , ...unction in many cellular processes, including the ...
(Date:11/19/2008)...19 Isogen, a contract development ...g, today announced the first,phase launch of its ...to,specifically address the process, facility and...2 billion highly-niched, low-volume clinical and,...ent. , Companies can invest over $100 milli...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX... and drug development Company,and Sosei Group Co...ading,international biopharmaceutical company, to...rther pivotal pre-clinical efficacy data for NSL-0...l therapy for neuropathic pain and has,successful...
(Date:11/18/2008)...18 Arlington Medical Resources (AM... the pharmaceutical and diagnostic,imaging indust... Privigen was,sold in the U.S. during the third q...ntravenous immune globulin (IVIG) and was launched...created from the blood plasma of thousands,of don...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 250 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 150 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 250 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 350 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 4SoluLinK Introduces ChromaLink 28TM 29 Biotin Labeling Kit to Biotinylate and Measure With One Reagent 2822 1SoluLinK Introduces ChromaLink 28TM 29 Biotin Labeling Kit to Biotinylate and Measure With One Reagent 2822 2Prison study to investigate link between diet and behavior 2042 1Prison study to investigate link between diet and behavior 2042 2Carbon monoxide may cause long lasting heart damage 2038 1Carbon monoxide may cause long lasting heart damage 2038 2
...mboEmbolism (VTE) is Reduced by a,Significant 43% ...xane(R) / Lovenox(R), BRIDGEWATER, N.J., April 20,...ounced the publication of the PREVAIL (Prevention,...parin) trial in,the April 21st issue of The Lancet...administration of Clexane(R) / Lovenox(R),(enoxapa...
... 23, 2007 - Ceragenix Pharmaceuticals,Inc. (OTCBB...ectious disease and dermatology, today announced t...ompany,s antimicrobial,compounds: CSA-8 and CSA-13...rnal of Antimicrobial Agents and Chemotherapy, a,p...ety of,Microbiology, dedicated to advances in the ...
Other Medicine Technology:The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 2The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 3The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 4The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 5The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 6Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4
The LH 755 simplifies and automates high-volume hematology testing by integrating expert automation and advanced technologies into one workcell. It delivers reliable, accurate results every time. Plu
Kinetic and endpoint methods for the quantitative determination of creatinine in serum.
For the quantitative determination of creatine kinase-MB in serum. Kinetic Reaction measured at 340 nm. Linearity: 700 IU/L at 37C.
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents.
Medicine Products: